Evidence map›Paper›PMID 36212132›Full record

ArticleFrontiers in genetics2022

A novel marker based on necroptosis-related long non-coding RNA for forecasting prognostic in patients with clear cell renal cell carcinoma.

Jinxing Lv, Qinghui Xu, Guoqing Wu, Jian Hou, Guang Yang, Cheng Tang, Genyi Qu, Yong Xu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jinxing LvDepartment of Urology, Zhuzhou Central Hospital, Zhuzhou, China.
Qinghui XuDepartment of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Guoqing WuDivision of Urology, Department of Surgery, The University of Hongkong-ShenZhen Ospital, ShenZhen, China.
Jian HouDivision of Urology, Department of Surgery, The University of Hongkong-ShenZhen Ospital, ShenZhen, China.
Guang YangDepartment of Urology, Zhuzhou Central Hospital, Zhuzhou, China.
Cheng TangDepartment of Urology, Zhuzhou Central Hospital, Zhuzhou, China.
Genyi QuDepartment of Urology, Zhuzhou Central Hospital, Zhuzhou, China.
Yong XuDepartment of Urology, Zhuzhou Central Hospital, Zhuzhou, China.
Zhuzhou Central Hospital · CNUniversity of Hong Kong - Shenzhen Hospital · CNFujian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

clear cell renal cell carcinomalong noncoding RNAnecroptosisprognosissignature

Identifiers

PMID36212132
PMCPMC9532702
OpenAlexW4296737067

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.